CalciMedica (NASDAQ:CALC) Given Buy Rating at HC Wainwright
HC Wainwright reissued their buy rating on shares of CalciMedica (NASDAQ:CALC – Free Report) in a report issued on Tuesday morning,Benzinga reports. HC Wainwright currently has a $16.00 price objective on the stock. CalciMedica Trading Up 2.1 % NASDAQ:CALC opened at $1.95 on Tuesday. The stock has a 50-day moving average price of $2.34 and […]
